EUVIMEDAtrasti EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 3.0

The Genetic and Molecular Drivers of Multiple Myeloma: Current Insights, Clinical Implications, and the Path Forward

Meghana Ram, Molly R Fraser, Junia Vieira Dos Santos, Rafail Tasakis, Ariana Islam, Jannah Usama Abo-Donia, Samir Parekh, Alessandro Lagana iD

Pharmacogenomics and Personalized Medicine · 2024-12 · Volume 17 · 573-609

DOI: 10.2147/pgpm.s350238 ↗

At a glance

Übersichtsarbeit in Pharmacogenomics and Personalized Medicine, 2024-12. Written by Meghana Ram and 7 co-authors. Institution: Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Cited 5 times so far (Crossref); 283 references. The full text is freely available (open access, CC BY-NC 3.0). Funded by: NCI NIH HHS.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Background

Multiple myeloma (MM) is a hematological malignancy characterized by the clonal proliferation of malignant plasma cells within the bone marrow. The disease's complexity is underpinned by a variety of genetic and molecular abnormalities that drive its progression.

Methods

This review was conducted through a state-of-The-art literature search, primarily utilizing PubMed to gather peer-reviewed articles. We focused on the most comprehensive and cited studies to ensure a thorough understanding of the genetic and molecular landscapes of MM.

Results

We detail primary and secondary alterations such as translocations, hyperdiploidy, single nucleotide variants (SNVs), copy number alterations (CNAs), gene fusions, epigenetic modifications, non-coding RNAs, germline predisposing variants, and the influence of the tumor microenvironment (TME). Our analysis highlights the heterogeneity of MM and the challenges it poses in treatment and prognosis, emphasizing the distinction between driver mutations, which actively contribute to oncogenesis, and passenger mutations, which arise due to genomic instability and do not contribute to disease progression. Conclusion & Future Perspectives: We report key controversies and challenges in defining the genetic drivers of MM, and examine their implications for future therapeutic strategies. We discuss the importance of systems biology approaches in understanding the dependencies and interactions among these alterations, particularly highlighting the impact of double and triple-hit scenarios on disease outcomes. By advancing our understanding of the molecular drivers and their interactions, this review sets the stage for novel therapeutic targets and strategies, ultimately aiming to improve clinical outcomes in MM patients.

Subjects

Author keywords

cancerepigeneticsfusionsmutationsmyelomancRNAtranslocations

Authors and institutions

  • Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Broad Institute of MIT and Harvard, Boston, MA, USA.
  • Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

ORCID profiles: Alessandro Lagana

Funding

  • NCI NIH HHS

Cite

APA

Ram, M., Fraser, M. R., Vieira Dos Santos, J., Tasakis, R., Islam, A., Abo-Donia, J. U., Parekh, S., & Lagana, A. (2024). The Genetic and Molecular Drivers of Multiple Myeloma: Current Insights, Clinical Implications, and the Path Forward. Pharmacogenomics and Personalized Medicine, Volume 17, 573-609. https://doi.org/10.2147/pgpm.s350238

Vancouver

Ram M, Fraser MR, Vieira Dos Santos J, Tasakis R, Islam A, Abo-Donia JU, et al. The Genetic and Molecular Drivers of Multiple Myeloma: Current Insights, Clinical Implications, and the Path Forward. Pharmacogenomics and Personalized Medicine. 2024;Volume 17:573-609. doi:10.2147/pgpm.s350238

BibTeX
@article{Ram2024,
  author = {Ram, Meghana and Fraser, Molly R and Vieira Dos Santos, Junia and Tasakis, Rafail and Islam, Ariana and Abo-Donia, Jannah Usama and Parekh, Samir and Lagana, Alessandro},
  title = {The Genetic and Molecular Drivers of Multiple Myeloma: Current Insights, Clinical Implications, and the Path Forward},
  journal = {Pharmacogenomics and Personalized Medicine},
  year = {2024},
  volume = {Volume 17},
  pages = {573--609},
  doi = {10.2147/pgpm.s350238}
}
Start for free →